CH618686A5 - - Google Patents
Download PDFInfo
- Publication number
- CH618686A5 CH618686A5 CH831576A CH831576A CH618686A5 CH 618686 A5 CH618686 A5 CH 618686A5 CH 831576 A CH831576 A CH 831576A CH 831576 A CH831576 A CH 831576A CH 618686 A5 CH618686 A5 CH 618686A5
- Authority
- CH
- Switzerland
- Prior art keywords
- lofepramine
- hydrochloride
- acetate
- solvent
- propyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB28145/75A GB1497306A (en) | 1975-07-03 | 1975-07-03 | Preparation of lofepramine and its hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH618686A5 true CH618686A5 (no) | 1980-08-15 |
Family
ID=10270996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH831576A CH618686A5 (no) | 1975-07-03 | 1976-06-29 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4172074A (no) |
| JP (1) | JPS6014030B2 (no) |
| BE (1) | BE843691A (no) |
| CA (1) | CA1079274A (no) |
| CH (1) | CH618686A5 (no) |
| DE (1) | DE2628558A1 (no) |
| FR (1) | FR2316234A1 (no) |
| GB (1) | GB1497306A (no) |
| IE (1) | IE43255B1 (no) |
| SE (1) | SE7607565L (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4108119A1 (de) * | 1991-03-13 | 1992-09-17 | Jellalabad Ltd | Verfahren zur herstellung von 4'-chlor-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl) methylaminno) acetophenon und seiner salze, die stabilisierungseiner salze, hierbei erhaeltliche produkte und pharmmazeutische zubereitungen, die diese enthalten |
| HU225493B1 (en) * | 1994-10-05 | 2007-01-29 | Amarin Neuroscience Ltd | Use of antidepressants, mao inhibitors and serotonine reuptake inhibitors for the treatment of multiple sclerosis (ms) and other demyelinating conditions |
| GB2308065B (en) * | 1994-10-05 | 1999-01-13 | Cari Loder | Treatment of multiple sclerosis (MS) and other demyelinating conditions |
| AU2004305563C1 (en) | 2003-12-11 | 2011-07-07 | Sunovion Pharmaceuticals Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| EP1793829A1 (en) * | 2004-10-01 | 2007-06-13 | Neurocure Ltd. | Use of pharmaceutical compositions of lofepramine for the treatment of adhd, cfs, fm and depression |
| EP2317316A3 (en) | 2005-07-08 | 2011-06-15 | Braincells, Inc. | Methods for identifying agent and conditions that modulate neurogenesis |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
| EP2125017A2 (en) * | 2007-01-11 | 2009-12-02 | Braincells, Inc. | Modulation of neurogenesis with use of modafinil |
| WO2009128058A1 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1177525A (en) * | 1967-04-13 | 1970-01-14 | Leo Ab | New Heterocyclic Aminoketones of Therapeutic Interest |
-
1975
- 1975-07-03 GB GB28145/75A patent/GB1497306A/en not_active Expired
-
1976
- 1976-06-21 US US05/697,764 patent/US4172074A/en not_active Expired - Lifetime
- 1976-06-23 CA CA255,508A patent/CA1079274A/en not_active Expired
- 1976-06-25 DE DE19762628558 patent/DE2628558A1/de active Granted
- 1976-06-29 CH CH831576A patent/CH618686A5/de not_active IP Right Cessation
- 1976-07-01 BE BE168562A patent/BE843691A/xx not_active IP Right Cessation
- 1976-07-01 SE SE7607565A patent/SE7607565L/xx unknown
- 1976-07-01 FR FR7620102A patent/FR2316234A1/fr active Granted
- 1976-07-02 IE IE1469/76A patent/IE43255B1/en unknown
- 1976-07-03 JP JP51078518A patent/JPS6014030B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE843691A (fr) | 1977-01-03 |
| IE43255L (en) | 1977-01-03 |
| DE2628558C2 (no) | 1989-11-16 |
| FR2316234A1 (fr) | 1977-01-28 |
| JPS527982A (en) | 1977-01-21 |
| GB1497306A (en) | 1978-01-05 |
| DE2628558A1 (de) | 1977-01-20 |
| FR2316234B1 (no) | 1979-06-08 |
| US4172074A (en) | 1979-10-23 |
| JPS6014030B2 (ja) | 1985-04-11 |
| CA1079274A (en) | 1980-06-10 |
| SE7607565L (sv) | 1977-01-04 |
| IE43255B1 (en) | 1981-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2628558C2 (no) | ||
| DE1962757C3 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2404946C3 (de) | Verfahren zur Herstellung von 7alpha-Acylthio-Steroidspirolactonen | |
| DE1912941C3 (de) | 1 -Phenyl^-amino-e-methoxypyridaziniumsalze | |
| DE2318767C3 (de) | Triamcinolon-Derivat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
| DE3026602A1 (de) | 14-oxo-15-halogen-e-homoeburnanderivate, verfahren zur herstellung derselben und von 14-oxo-15-hydroxyimino-e-homoeburnanderivaten und die ersteren enthaltende arzneimittel | |
| DE1695212B2 (de) | Verfahren zur Herstellung von Iodininderivaten | |
| AT326638B (de) | Verfahren zur herstellung von n(beta-diäthylaminoäthyl) -4-amino-5-chlor-2-methoxybenzamid | |
| DE1960130A1 (de) | Neue Verfahren zur Herstellung von N-(Diaethylaminoaethyl)-4-amino-5-chloro-2-methoxybenzamid | |
| DE2331044A1 (de) | Diphenylmethan-derivate und verfahren zu deren herstellung | |
| DE2236005C3 (de) | Dibenzo- eckige Klammer auf d,f eckige Klammer zu -dioxepin- eckige Klammer auf 1,3 eckige Klammer zu -derivate und deren pharmakologisch verträgliche Salze, sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE1092932B (de) | Verfahren zur Herstellung amoebicid wirksamer N-Dichloracet-oxy-anilid-Ester | |
| DE2166662A1 (de) | Tricyclische derivate von aliphatischen omega-alkoholen und verfahren zu ihrer herstellung | |
| DE2403682C3 (de) | S-Methyl-Z-phenyl-S-benzothiazolln-esslgsäure-Verbindungen und Verfahren zu ihrer Herstellung | |
| DE1929237A1 (de) | Verfahren zur Herstellung von N-Acyl-3,4-epoxy-pyrrolidin-Derivaten | |
| DE1002347C2 (de) | Verfahren zur Herstellung von in 4(5)-Stellung ungesaettigten 2-Jodsteroid-3-ketonen bzw. Steroid-3-ketonen | |
| EP0150411A1 (de) | Verfahren zur Herstellung substituierter Chinazolin-2.4(1H.3H)-dione | |
| AT239226B (de) | Verfahren zur Herstellung von neuen, substituierten 2-Oxo-tetrahydrochinolinen | |
| AT209007B (de) | Verfahren zur Herstellung von 9 α-Halogen-4-pregnen-16 α, 17 α,21-triol-3, 11, 20-trionen und ihren Estern | |
| DE2344510C3 (de) | Glycyrrhetinsäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
| DE3511149A1 (de) | Verfahren zur herstellung von 2,2-bis-halogenmethylpenam-derivaten | |
| DE1966212A1 (de) | Neue Verfahren zur Herstellung von N-(Diaethylaminoaethyl)-4-amino-5-chloro-2-methoxybenzamid | |
| DE3431009A1 (de) | Verfahren zur herstellung von 6-demethyl-6-desoxy-6-methylen-5-oxytetracyclin und dessen 11a-chlorderivat | |
| DE1145617B (de) | Verfahren zur Herstellung von Trialkoxybenzoesaeureestern des 3-Chlor-10-{3-[4-(ª‰-oxyaethyl)-piperazino]-propyl}-phenthiazins | |
| DE2023048A1 (de) | Verfahren zur Herstellung von 4,5 alpha-Oxido-bufa-dienolid-3-[rhamnosido-2',3'-dialkylorthocarbonaten] |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PFA | Name/firm changed |
Owner name: PHARMACIA BIOSYSTEMS AB |
|
| PUE | Assignment |
Owner name: PHARMACIA AKTIEBOLAG |
|
| PL | Patent ceased |